EGFR and non-small cell lung carcinoma: To our concern, 343 NSCLC patients received re-biopsy and 24 SCLC transformation cases were confirmed (24/343, 7.0%) including 13 EGFR mutant, 2 with positive ALK rearrangement and 9 wildtypes for either detected driver genes (Table 2).